Parallel Advisors’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.22K | Sell |
2,688
-631
| -19% | -$2.16K | ﹤0.01% | 2487 |
|
|
2025
Q1 | $7.4K | Buy |
3,319
+223
| +7% | +$497 | ﹤0.01% | 2537 |
|
|
2024
Q4 | $9.07K | Buy |
3,096
+1,098
| +55% | +$3.22K | ﹤0.01% | 2418 |
|
|
2024
Q3 | $5.2K | Buy |
1,998
+893
| +81% | +$2.32K | ﹤0.01% | 2581 |
|
|
2024
Q2 | $3.27K | Sell |
1,105
-1,363
| -55% | -$4.04K | ﹤0.01% | 2639 |
|
|
2024
Q1 | $11.2K | Hold |
2,468
| – | – | ﹤0.01% | 2257 |
|
|
2023
Q4 | $14.1K | Buy |
2,468
+1,930
| +359% | +$11K | ﹤0.01% | 2135 |
|
|
2023
Q3 | $2.48K | Buy |
538
+114
| +27% | +$524 | ﹤0.01% | 2748 |
|
|
2023
Q2 | $2.74K | Buy |
424
+123
| +41% | +$795 | ﹤0.01% | 2660 |
|
|
2023
Q1 | $2.27K | Buy |
301
+122
| +68% | +$920 | ﹤0.01% | 2720 |
|
|
2022
Q4 | $1.81K | Buy |
+179
| New | +$1.81K | ﹤0.01% | 2717 |
|